Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany

NCT02125604 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

214

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-Remitting Multiple Sclerosis

Interventions

DRUG: dimethyl fumarate

Sponsor

Biogen